Resonance Health (ASX:RHT) 3-Year Revenue Growth Rate : 33.40% (As of Jun. 2024)

View and export this data going back to 1987. Start your Free Trial

What is Resonance Health 3-Year Revenue Growth Rate?

Resonance Health's Revenue per Share for the six months ended in Jun. 2024 was A$0.01.

During the past 12 months, Resonance Health's average Revenue per Share Growth Rate was 90.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 33.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 13.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Resonance Health was 81.70% per year. The lowest was -12.60% per year. And the median was 7.70% per year.

Competitive Comparison of Resonance Health's 3-Year Revenue Growth Rate

For the Health Information Services subindustry, Resonance Health's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resonance Health's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Resonance Health's 3-Year Revenue Growth Rate falls into.

Resonance Health 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Resonance Health (ASX:RHT) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Resonance Health 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Resonance Health's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonance Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Resonance Health Ltd (ASX:RHT) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

141-143 Burswood Road, Level 1, Burswood, Perth, WA, AUS, 6100

Website

https://www.resonancehealth.com

Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, Cardiac T2, and HepaFat-Scan. It also has several AI-assisted SaMDs including FerriSmart, HepaFat-AI, and LiverSmart. The company's business segments are; Services which derives key revenue, Research and development, Corporate, Clinical Research Organization (CRO), and TrialsWest. Geographically, it generates maximum revenue from the Asia Pacific and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.

Resonance Health Headlines

No Headlines